*Values are no. (%) patients except as indicated. CoV, coronavirus; DM, diabetes mellitus; MERS, Middle East respiratory syndrome; NA, not applicable.
†p values are for Fisher exact or Kruskall–Wallis tests comparing long-term and short-term.
‡Based on documented medical history of DM; comparison excludes 1 patient with possible DM status; total, N = 18; prolonged shedding >11 days, n = 7.
§Includes 7 patients with a documented history of DM and 1 patient (of possible DM status) who had no documented history of DM but exhibited multiple periods of hyperglycemia (>200 mg/dL) during hospitalization, with a maximum random glucose reading of 404 mg/dL.
¶Cardiac disease includes congestive heart failure, coronary artery disease, a history of coronary artery bypass, or a history of myocardial infarction. Reports of isolated hypertension were not included.
#Pulmonary disease includes chronic obstructive pulmonary disease, asthma or reactive airway disease, or use of supplemental oxygen at home.
**Patient who was on supplemental oxygen (bilevel positive airway pressure) at home required mechanical ventilation when hospitalized.
††Secondary exposure defined as reported contact with a known MERS case-patient.
‡‡No recognized risks defined as no reported contact with a known MERS case-patient or camel (direct or indirect contact).
§§Comparison excludes 2 patients with multiple exposures; total, N = 17; shed <11 days, n = 10; shed >11 days, n = 7.
¶¶Primary exposure defined as no reported contact with a known MERS case-patient; includes direct camel contact and patients with no recognized risks.